United States · Law · HR
H.R. 4014 (107th)
Rare Diseases Orphan Product Development Act of 2002
Introduced
20 March 2002
Last action
—
Status
Became Public Law No: 107-281.
Sponsors
—
Subjects
Discovery layer
Source updated
7 April 2025
Summary
Rare Diseases Orphan Product Development Act of 2002 - Amends the Orphan Drug Act to authorize appropriations for FY 2002 through 2006 for grants and contracts for the development of drugs for rare diseases and conditions.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
14 official files
Enrolled Bill (text)
Enrolled Bill (text)
Enrolled Bill · EN
Enrolled Bill (PDF)
Enrolled Bill · EN
Public Law (text)
Public Law · EN · 6 November 2002
Public Law (PDF)
Public Law · EN · 6 November 2002
Received in Senate (text)
Received in Senate · EN · 2 October 2002
Received in Senate (PDF)
Received in Senate · EN · 2 October 2002
Engrossed in House (text)
Engrossed in House · EN · 1 October 2002
Engrossed in House (PDF)
Engrossed in House · EN · 1 October 2002
Reported in House (text)
Reported in House · EN · 1 October 2002
Reported in House (PDF)
Reported in House · EN · 1 October 2002
Passed House without amendment
summary · EN · 1 October 2002
Introduced in House (text)
Introduced in House · EN · 20 March 2002
Introduced in House (PDF)
Introduced in House · EN · 20 March 2002
Introduced in House
summary · EN · 20 March 2002
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/107th-congress/house-bill/4014
- Open data entity: https://api.congress.gov/v3/bill/107/hr/4014